DCBs Improve 6-Month Patency in Dysfunctional Hemodialysis AV Fistulas, Study Shows
In patients with dysfunctional hemodialysis (HD) arteriovenous fistulas (AVFs), drug-coated balloons (DCBs) were superior to standard angioplasty (SA) with regard to 6-month patency and had non-inferior 30-day access circuit-related serious adverse events.